197 related articles for article (PubMed ID: 17297263)
1. Relationship of serum adiponectin and resistin levels with breast cancer risk.
Kang JH; Yu BY; Youn DS
J Korean Med Sci; 2007 Feb; 22(1):117-21. PubMed ID: 17297263
[TBL] [Abstract][Full Text] [Related]
2. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas.
Demir N; Ahıshalı E; Dolapçıoğlu C; Ercan Ş; Orçun Kaptanağası A; Dabak R; Yücel N; Sargın M; Uygur Bayramiçli O
Turk J Gastroenterol; 2015 Jan; 26(1):20-4. PubMed ID: 25698266
[TBL] [Abstract][Full Text] [Related]
4. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
5. Serum resistin is inversely related to breast cancer risk in premenopausal women.
Georgiou GP; Provatopoulou X; Kalogera E; Siasos G; Menenakos E; Zografos GC; Gounaris A
Breast; 2016 Oct; 29():163-9. PubMed ID: 27521488
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease.
Atwa M; Emara A; Balata M; Youssef N; Bayoumy N; Sherif A; Fiala L
Int J Dermatol; 2014 Oct; 53(10):e410-20. PubMed ID: 24168156
[TBL] [Abstract][Full Text] [Related]
7. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity.
Zou CC; Liang L; Hong F
Indian Pediatr; 2007 Apr; 44(4):275-9. PubMed ID: 17468522
[TBL] [Abstract][Full Text] [Related]
8. Hyperresistinemia is associated with postmenopausal breast cancer.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
[TBL] [Abstract][Full Text] [Related]
9. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension.
Papadopoulos DP; Makris TK; Perrea D; Papazachou O; Daskalaki M; Sanidas E; Votteas V
Blood Press; 2008; 17(1):50-4. PubMed ID: 18568692
[TBL] [Abstract][Full Text] [Related]
11. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
Filippidis G; Liakopoulos V; Mertens PR; Kiropoulos T; Stakias N; Verikouki C; Patsidis E; Koukoulis G; Stefanidis I
Blood Purif; 2005; 23(6):421-8. PubMed ID: 16141714
[TBL] [Abstract][Full Text] [Related]
12. Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley.
Shahar S; Salleh RM; Ghazali AR; Koon PB; Mohamud WN
Asian Pac J Cancer Prev; 2010; 11(1):61-6. PubMed ID: 20593932
[TBL] [Abstract][Full Text] [Related]
13. Adipocytokine resistin and breast cancer risk.
Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
[TBL] [Abstract][Full Text] [Related]
14. Association of serum adiponectin levels with breast cancer risk.
Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.
Dalamaga M; Karmaniolas K; Nikolaidou A; Chamberland J; Hsi A; Dionyssiou-Asteriou A; Mantzoros CS
Eur J Cancer; 2008 Aug; 44(12):1744-53. PubMed ID: 18515085
[TBL] [Abstract][Full Text] [Related]
17. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
19. Association of circulating leptin, adiponectin, and resistin concentrations with long-term breast cancer prognosis in a German patient cohort.
Obi N; Jung AY; Maurer T; Huebner M; Johnson T; Behrens S; Jaskulski S; Becher H; Chang-Claude J
Sci Rep; 2021 Dec; 11(1):23526. PubMed ID: 34876619
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study.
Saito T; Yamaguchi N; Shimazaki Y; Hayashida H; Yonemoto K; Doi Y; Kiyohara Y; Iida M; Yamashita Y
J Dent Res; 2008 Apr; 87(4):319-22. PubMed ID: 18362311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
